Phathom Pharmaceuticals Inc
Phathom Pharmaceuticals Inc (PHAT) Option Chain
As of September 18, 2026, Phathom Pharmaceuticals Inc is trading at $7.48, a -3.49% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 87.8%. IV Rank is 4%.
Read more
Tracking the PHAT option chain helps you see every strike and expiry on Phathom Pharmaceuticals Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Phathom Pharmaceuticals Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of PHAT options activity at a glance. Use our scanner to monitor the PHAT option chain in real time and filter for the PHAT options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For PHAT stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the PHAT option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where PHAT stock options are being actively traded and where they are not.
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan, which is in Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. Phathom Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Florham Park, New Jersey.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Phathom Pharmaceuticals Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen PHAT options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of PHAT stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile9.13% Subdued
- Market cap (M$)605
- 52 weeks high-59.15%
- 52 weeks low0.27%
- Analyst recommendationStrong Buy
1.45 - Target price$20.45
173.40% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-10-29
- P/E—
- Future P/E9.59
- EPS (ttm)-1.27
- EPS growth next 5 years—
As of September 18, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| Loading option chain… | |||||||||||||||
As of September 18, 2026
Scan the full option chain in one place
Browse the full PHAT option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→